COMMUNIQUÉS West-GlobeNewswire

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
08/01/2026
SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann [...]
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
08/01/2026
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock New Market [...]
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
08/01/2026
Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive preliminary results from [...]
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
08/01/2026
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
08/01/2026
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health [...]
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
08/01/2026
Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium Presentation HOUSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage [...]
ClinNEXUS Launches New Corporate Rebranding to Kick Off Attendance During Week of J.P. Morgan Healthcare Conference
08/01/2026
-Updated logo and website better reflect patient-centric focus and accessibility as well as new inflection point for company- -ClinNEXUS management will be in attendance during “JPM Week” hosting investor meetings and [...]
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
08/01/2026
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, unaudited topline [...]
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System
08/01/2026
twiist™ becomes the first AID system compatible with Senseonics Eversense® 365 one-year CGM GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company [...]
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
08/01/2026
SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart or “the Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its [...]
Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis
08/01/2026
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespective of modulator- [...]
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
08/01/2026
-- Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX [...]
Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)
08/01/2026
– Once-weekly TransCon ® CNP and TransCon ® hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks – Annualized growth velocity (AGV) exceeded the 97th-percentile of [...]
Syneos Health Appoints Simon Bartle as Chief Human Resources Officer
08/01/2026
Scaling People Practices for High Performance MORRISVILLE, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Syneos Health, a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of [...]
Valneva SE - Declaration of voting rights - December 2025
08/01/2026
VALNEVA Declaration of shares and voting rights December 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint Joseph [...]
Déclaration d'actions et de droits de vote de la société Valneva SE - décembre 2025
08/01/2026
VALNEVA Déclaration d’actions et de droits de vote 31 décembre 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : [...]
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
08/01/2026
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation Award Expands iNKT platform into transplantation with an off-the-shelf, HLA-independent, lymphodepletion-free [...]
Easy Environmental Solutions Enters 2026 With Accelerated Global Momentum and a Clear Path to Scale
08/01/2026
Company surpasses 2025 international development targets and advances toward multi-continent deployment of disruptive integrated soil and water technologies MANKATO, Minn., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Easy [...]
Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles
08/01/2026
Worcester, Massachusetts, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST ), a diversified innovation company with operations spanning eco-friendly products and collectibles monetization, today [...]

Pages